Search Browse Earnings

Scilex Holding Co

Nasdaq:SCLXNasdaq:SCLXW

Biological Products, (No Diagnostic Substances)·PALO ALTO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$46.7M

+49.3% YoY

FY 2024

Adj. EBITDA

-$101.3M

-216.7% margin

FY 2024

Net Income

-$114.3M

-244.6% margin

FY 2024

EPS (Diluted)

-$1.28

FY 2024

Stock Price

$8.58

+2.1%

2026-03-09

52W Range

$3.60 – $34.27

P/E Ratio

-6.7x

Market Cap

$65.1M

Cash

$3.9M

FY 2024

Total Debt

$180.5M

FY 2022

Net Debt

$176.5M

FY 2022

Enterprise Value

$241.6M

Debt / EBITDA

-1.7x

FY 2024

EV / EBITDA

-2.4x

Employees

—